Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Rambeck

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Therapeutic Drug Monitoring|May 22, 2002
Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedicationTheodor W May, Bernhard Rambeck, Uwe Jürgens
Therapeutic Drug Monitoring|November 26, 2003
Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medicationTheodor W May, Bernhard Rambeck, Uwe Jürgens
Clinical Pharmacokinetics|September 10, 2003
Clinical pharmacokinetics of oxcarbazepineTheodor W May, Elisabeth Korn-Merker, Bernhard Rambeck
Therapeutic Drug Monitoring|September 28, 2002
Does lamotrigine influence valproate concentrations?Mihaela-Irina Mataringa, Theodor W May, Bernhard Rambeck
Therapeutic Drug Monitoring|November 29, 2007
Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedicationTheodor W May, Bernhard Rambeck, Roland Neb, et al.
Pharmaceutical Research|September 5, 2009
The antiepileptic drug topiramate is a substrate for human P-glycoprotein but not multidrug resistance proteinsCarlos Luna-Tortós, Bernhard Rambeck, Uwe H Jürgens, et al.
Epilepsy Research|May 6, 2011
Fluctuation of lacosamide serum concentrations during the day and occurrence of adverse drug reactions--first clinical experienceAnnika Sattler, Marion Schaefer, Theodor W May, et al.
Epilepsy & Behavior : E&B|July 24, 2012
Symptoms and course of intoxication with mesuximide--a case reportRobert Hoepner, Theodor W May, Bernhard Rambeck, et al.
Therapeutic Drug Monitoring|March 9, 2011
Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedicationTheodor W May, Rainer Boor, Bernhard Rambeck, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|September 16, 2005
Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapyWalter Fröscher, Katja R Schier, Markus Hoffmann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Therapeutic Drug Monitoring|May 22, 2002
Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedicationTheodor W May, Bernhard Rambeck, Uwe Jürgens
Therapeutic Drug Monitoring|November 26, 2003
Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medicationTheodor W May, Bernhard Rambeck, Uwe Jürgens
Clinical Pharmacokinetics|September 10, 2003
Clinical pharmacokinetics of oxcarbazepineTheodor W May, Elisabeth Korn-Merker, Bernhard Rambeck
Therapeutic Drug Monitoring|September 28, 2002
Does lamotrigine influence valproate concentrations?Mihaela-Irina Mataringa, Theodor W May, Bernhard Rambeck
Therapeutic Drug Monitoring|November 29, 2007
Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedicationTheodor W May, Bernhard Rambeck, Roland Neb, et al.
Pharmaceutical Research|September 5, 2009
The antiepileptic drug topiramate is a substrate for human P-glycoprotein but not multidrug resistance proteinsCarlos Luna-Tortós, Bernhard Rambeck, Uwe H Jürgens, et al.
Epilepsy Research|May 6, 2011
Fluctuation of lacosamide serum concentrations during the day and occurrence of adverse drug reactions--first clinical experienceAnnika Sattler, Marion Schaefer, Theodor W May, et al.
Epilepsy & Behavior : E&B|July 24, 2012
Symptoms and course of intoxication with mesuximide--a case reportRobert Hoepner, Theodor W May, Bernhard Rambeck, et al.
Therapeutic Drug Monitoring|March 9, 2011
Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedicationTheodor W May, Rainer Boor, Bernhard Rambeck, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|September 16, 2005
Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapyWalter Fröscher, Katja R Schier, Markus Hoffmann, et al.
Pageof 2